'Myotonic dystrophy' diaporamas de présentation

Approach to myopathy

Approach to myopathy. The first goal in approaching a patient with a suspected muscle disease is to determine the correct site of the lesion. The second goal is to determine the cause of the myopathy.

1.68k views • 83 slides

Approach to myopathy

Approach to myopathy. The first goal in approaching a patient with a suspected muscle disease is to determine the correct site of the lesion. The second goal is to determine the cause of the myopathy.

992 views • 83 slides

????? ????????? ?????? ???????????????

????? ????????? ?????? ???????????????. ????? ??. Muscular Dystrophies. ????? ????? ?????? ????????? ?????? ????? ?????? ???????? ?? ???? ???????? ???????????? ???????? ????? ????? ??? ?????? ????? ????? ???? ??????? ????????

874 views • 71 slides

???? ??????? ?? ??? ??? ?????? ????? ???? ????

???? ??????? ?? ??? ??? ?????? ????? ???? ???? . Pediatric cataracts , case selection before surgery Dr.Sayed Ezatollah Memarzadeh ophthalmologist Esfahan 1391. EPIDEMIOLOGY . 1 In every 250 newborn has lens opacity most of them are not visually significant

824 views • 65 slides

Muscular dystrophy

Muscular dystrophy. Dr. Derakhshandeh. Muscular dystrophy. Muscular dystrophy (MD) is a group of rare inherited muscle diseases in which muscle fibers are unusually susceptible to damage. Muscles, primarily voluntary muscles, become progressively weaker

1.28k views • 38 slides

Case Discussion 17 y/o girl with congenital myopathy

Case Discussion 17 y/o girl with congenital myopathy. Ri ??? ? SC ???. Brief History-1. 82 (7y/o): exercise difficulty 86/10 (11y/o): scoliosis s/p Milwaukee brace at McKay Hospital 87/4 (12y/o): Progressive unsteady gait, dyspnea and consciousness loss

936 views • 37 slides

Muscular Dystrophies

Muscular Dystrophies. What is Muscular Dystrophy? (MD). Muscular D ystrophy is a group of genetic disorders that cause progressive muscle weakness. MD is caused by a genetic mutation. The protein in the muscle is deformed which causes the patients muscle to deteriorate.

1.86k views • 35 slides

Neonatal Hypotonia Clinical Approach To Floppy Baby

Neonatal Hypotonia Clinical Approach To Floppy Baby. Osama Naga, M.D., PGY2 7/23/09. Neonatal Hypotonia. Central Causes Cerebral palsy Hypoxic ischemic encephalopathy Intracranial hemorrhage Cerebral malformations Chromosomal abnormalities (e.g.Trisomy 21, Prader-Willi syndrome)

832 views • 31 slides

MYOTONIC MUSCLE DISORDERS

MYOTONIC MUSCLE DISORDERS. By Radwa ElKhouly Assistant lecturer of Physical Medicine and Rheumatology Tanta university. The myotonic muscle disorders and periodic paralysis syndromes.

423 views • 29 slides

Atypical Patterns of Inheritance

Medical Genetics. LECTURE 4 M. Faiyaz-Ul-Haque , PhD, FRCPath. Atypical Patterns of Inheritance. Lecture Objectives. By the end of this lecture, students should be able to appreciate the possibility of atypical patterns of inheritance with special emphasis on: Codominant traits

454 views • 28 slides

DNA Sequencing

LECTURE 6 :. DNA Sequencing . Biotechnology; 3 Credit hours Atta- ur - Rahman School of Applied Biosciences (ASAB) National University of Sciences and Technology (NUST). Introduction . In 1953, two researchers, namely James Watson and Francis Crick, discovered the basic structure of DNA

558 views • 21 slides

OPHTHALMOLOGY CATARACTS

OPHTHALMOLOGY CATARACTS. MBChB 4 Prof P Roux 2012. ACQUIRED CATARACT. 1. Classification of age-related cataract. Morphological. According to maturity. 2. Other causes of cataracts. Diabetes. Myotonic dystrophy. Atopic dermatitis. Trauma. Drugs. Secondary (complicated).

644 views • 17 slides

valentiabiopharma info@valentiabiopharma

www.valentiabiopharma.com info@valentiabiopharma.com. Valentia Biopharma - In vivo Drug Discovery. Research and development of new drugs for human diseases. Currently focused on finding lead compounds to achieve an effective treatment on Myotonic Dystrophy Type 1 (DM1) disease.

248 views • 13 slides

Information on Therapeutic Development for Myotonic Dystroph

180 views • 6 slides

Myotonic Dystrophy Pipeline Therapeutics Assessment Review H2 2015

This report provides comprehensive information on the therapeutic development for Myotonic Dystrophy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Myotonic Dystrophy and special features on late-stage and discontinued projects

246 views • 6 slides